Business Description
Brooks Laboratories Ltd
NAICS : 325412
SIC : 2834
ISIN : INE650L01011
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.43 | |||||
Interest Coverage | 2.76 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.78 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.3 | |||||
3-Year EPS without NRI Growth Rate | -3 | |||||
3-Year FCF Growth Rate | -104.5 | |||||
3-Year Book Growth Rate | -7.7 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.73 | |||||
9-Day RSI | 50.93 | |||||
14-Day RSI | 48.86 | |||||
6-1 Month Momentum % | -55.16 | |||||
12-1 Month Momentum % | -2.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 0.93 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 83.05 | |||||
Days Sales Outstanding | 85.49 | |||||
Days Payable | 148.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 4.42 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.45 | |||||
Operating Margin % | 2.92 | |||||
Net Margin % | -23.71 | |||||
FCF Margin % | -15.87 | |||||
ROE % | -20.75 | |||||
ROA % | -14.82 | |||||
ROIC % | 2.22 | |||||
ROC (Joel Greenblatt) % | -69.48 | |||||
ROCE % | -19.18 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.48 | |||||
PB Ratio | 3.48 | |||||
Price-to-Tangible-Book | 3.48 | |||||
EV-to-EBIT | -16.05 | |||||
EV-to-EBITDA | -17.68 | |||||
EV-to-Revenue | 3.63 | |||||
EV-to-FCF | -22.87 | |||||
Price-to-Median-PS-Value | 1.58 | |||||
Price-to-Net-Current-Asset-Value | 36.85 | |||||
Earnings Yield (Greenblatt) % | -6.23 | |||||
FCF Yield % | -4.43 | |||||
Forward Rate of Return (Yacktman) % | -14.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Brooks Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 637.834 | ||
EPS (TTM) (₹) | -5.92 | ||
Beta | 1.53 | ||
Volatility % | 54.34 | ||
14-Day RSI | 48.86 | ||
14-Day ATR (₹) | 3.555993 | ||
20-Day SMA (₹) | 86.046 | ||
12-1 Month Momentum % | -2.37 | ||
52-Week Range (₹) | 72.51 - 185.15 | ||
Shares Outstanding (Mil) | 26.25 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Brooks Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Brooks Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Brooks Laboratories Ltd Frequently Asked Questions
What is Brooks Laboratories Ltd(BOM:533543)'s stock price today?
When is next earnings date of Brooks Laboratories Ltd(BOM:533543)?
Does Brooks Laboratories Ltd(BOM:533543) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |